![Uwe Schoenbeck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Uwe Schoenbeck
Director/Board Member at Alterome Therapeutics, Inc.
Uwe Schoenbeck active positions
Companies | Position | Start | End |
---|---|---|---|
Canaan Management, Inc.
![]() Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Private Equity Investor | - | - |
Alterome Therapeutics, Inc.
![]() Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Director/Board Member | - | - |
Career history of Uwe Schoenbeck
Statistics
International
United States | 3 |
Operational
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectoral
Finance | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Canaan Management, Inc.
![]() Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Finance |
Alterome Therapeutics, Inc.
![]() Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Health Technology |
- Stock Market
- Insiders
- Uwe Schoenbeck
- Experience